title: Endophthalmitis after intravitreal injection of frozen preprepared tissue plasminogen activator (tPA) for pneumatic displacement of submacular hemorrhage.
authors.affiliation: Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
authors.forename: Brendan J
authors.initials: BJ
authors.lastname: Vote
authors.forename: Robert
authors.initials: R
authors.lastname: Buttery
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Polkinghorne
mesh_terms: D000368:Aged; D015925:Cryopreservation; D004340:Drug Contamination; D009877:Endophthalmitis / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000635:transmission*; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D016908:Gram-Positive Bacterial Infections / Q000635:transmission*; D006801:Humans; D007267:Injections; D011425:Propionibacterium acnes / Q000302:isolation & purification*; D012166:Retinal Hemorrhage / Q000628:therapy*; D013291:Streptococcus / Q000302:isolation & purification*; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use; D014822:Vitreous Body
chemical_list: D005466:Fluorocarbons; C042852:perflutren; D010959:Tissue Plasminogen Activator; D013459:Sulfur Hexafluoride